Article
Effects of niceritrol on levels of serum lipids, lipoprotein(a), and fibrinogen in patients with primary hypercholesterolemia.
Atherosclerosis - 1 Jun 1992
Matsunaga A, Handa K, Mori T, Moriyama K, Hidaka K, Yuki M, Sasaki J, Arakawa K
Abstract excerpt
Thirty-three consecutive unselected patients with primary hypercholesterolemia received niceritrol 1.5 g daily for 12 weeks, with the effect of administering divided dose (twice daily (b.i.d.) and three times daily (t.i.d.)) evaluated. The serum concentrations of lipoprotein(a) (Lp(a)), lipids, t...
Topics
- Adult
- Aged
- Apolipoproteins
- Apolipoproteins E
- Carrier Proteins
- Cholesterol
- Cholesterol Ester Transfer Proteins
- Cholesterol, HDL
- Cholesterol, LDL
- Female
- Fibrinogen
- Glycoproteins
- Humans
- Hypercholesterolemia
- Lipids
- Lipoprotein(a)
- Lipoproteins
- Male
